Raymond James Financial
PRAX icon

Raymond James Financial’s Praxis Precision Medicines PRAX Stock Holding History

Raymond James Financial’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.8M Buy
61,980
+56,660
+1,065% +$17.9M 0.01% 1535
2026
Q1 		$1.71M Buy
5,320
+85
+2% +$26.3K ﹤0.01% 3464
2025
Q4 		$1.54M Buy
+5,235
New +$975K ﹤0.01% 3475

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Raymond James Financial's PRAX Position: Q2 2026 in Review

Raymond James Financial increased its Praxis Precision Medicines (PRAX) stake by 1,065% in Q2 2026, buying an estimated $17.9M and bringing the position to 61,980 shares worth $20.8M. The position accounts for 0.01% of the portfolio, ranked #1535.

Raymond James Financial first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Raymond James Financial held 61,980 shares of Praxis Precision Medicines worth $20.8M as of Q2 2026.
  • Raymond James Financial bought 56,660 Praxis Precision Medicines shares in Q2 2026, an estimated $17.9M.
  • Praxis Precision Medicines made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1535 holding.
  • Raymond James Financial first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.